Every story in this section, newest first — page 212 of 373.
In a significant move for pharmaceutical transparency, the Bristol Myers Squibb-Pfizer Alliance announced that Eliquis® (apixaban), one of the world’s most widely prescribed blood thinners, will soon be available through Mark Cuban’s direct-to-consumer pharmacy.
Ponce Financial Group (NASDAQ:PDLB) reported a profitable start to 2026, characterized by a double-digit rise in shareholder equity and a stable interest margin that underscores the lender’s successful navigation of the current rate environment.
The Western Union Company (NYSE:WU) reported mixed first-quarter results as the legacy remittance giant works to offset retail headwinds in the Americas through an aggressive digital expansion and a foray into blockchain-native payment systems.
ChoiceOne Financial Services NASDAQ:COFS) reported a strong start to 2026, driven by a significant expansion in its net interest margin and robust organic deposit growth that fortified the community bank’s balance sheet.
WiMi Hologram Cloud (NASDAQ:WIMI) reported a massive surge in annual profitability for 2025, underscoring a successful transition toward leaner operations and a significantly fortified balance sheet.
HCA Healthcare (NYSE:HCA) posted a solid start to 2026, delivering a double-digit increase in earnings per share as steady patient volumes and operational "resiliency" initiatives helped the hospital giant navigate a complex reimbursement landscape.
Charter Communications (NASDAQ:CHTR) reported a slight dip in first-quarter revenue and earnings, as record-breaking growth in its mobile segment struggled to fully compensate for a cooling residential broadband market.
The Procter & Gamble Company (NYSE:PG) reported a robust rise in third-quarter sales and earnings, underpinned by steady consumer demand and a strategic portfolio adjustment that provided a significant boost to the bottom line.
SLB reported a slight increase in first-quarter revenue, but the world’s largest oilfield services provider saw its earnings retreat as production disruptions in the Middle East pressured operational margins and dampened bottom-line performance.
Merck (NYSE:MRK) has moved a step closer to finalizing its multi-billion dollar bet on the next generation of blood cancer treatments, clearing a key federal antitrust review for its acquisition of Terns Pharmaceuticals.
Rithm Property Trust reported a net loss for the first quarter of 2026 as market-driven adjustments weighed on comprehensive income, though the real estate investment platform maintained its quarterly dividend distribution.
Arrowhead Pharmaceuticals is on the verge of its first European commercial launch after regulatory advisors recommended the approval of its siRNA therapy, REDEMPLO, for a rare and potentially life-threatening lipid disorder.
The Gorman-Rupp Company (NYSE:GRC) announced its latest quarterly payout to shareholders on Friday, extending one of the longest continuous dividend streaks in the industrial sector on the back of record-breaking quarterly earnings.
Apogee Enterprises (NASDAQ:APOG) reported a steady climb in annual revenue for fiscal 2026, meeting its full-year targets as the company leverages its "Project Fortify" efficiency gains to navigate a complex commercial construction market.
Haemonetics (NYSE:HAE) announced new clinical data demonstrating superior safety for its vascular closure technology, just weeks after receiving expanded U.S. regulatory clearance to address a wider range of complex cardiac procedures.
Nano Labs (NASDAQ:NA) and ALT5 Sigma Corporation signed a memorandum of understanding on Friday to evaluate a wide-ranging collaboration, aiming to combine high-performance computing hardware with institutional-grade financial settlement for the burgeoning AI economy.
Flagstar Bank (NYSE:FLG) posted its second consecutive quarter of profitability, buoyed by a significant expansion in its commercial loan portfolio and a disciplined reduction in operating expenses that helped the regional lender navigate a shifting interest rate environment.
Intel (NASDAQ:INTC) shares surged as much as 20% in after-hours trading Thursday, after the semiconductor pioneer reported quarterly results that cleared Wall Street estimates and offered the clearest evidence yet that its transition into an AI-centric hardware provider is gaining momentum.
TotalEnergies (NYSE:TTE) reached a definitive milestone in its Central Asian expansion, announcing a Final Investment Decision (FID) for the Mirny wind project in Kazakhstan, a massive renewable energy hub backed by an international consortium of lenders.
L3Harris Technologies (NYSE:LHX) announced the closure of a $1 billion strategic investment from the Department of Defense (DoD) into its newly formed Missile Solutions (MSL) business.
PENN Entertainment (NASDAQ:PENN), a leading provider of integrated entertainment, sports content, and casino gaming, reported financial results for the first quarter ended March 31, 2026, showcasing a narrowing loss and strong digital momentum.
Altisource Portfolio Solutions (NASDAQ:ASPS) delivered a robust performance for the first quarter of 2026, marking a pivotal turn in its operational efficiency and market positioning.
Helen of Troy (NASDAQ:HELE), the designer and marketer of brands including OXO, Hydro Flask, and Osprey, reported a challenging fourth quarter for fiscal 2026, marked by significant non-cash charges and persistent macroeconomic pressure.
Lockheed Martin (NYSE:LMT) today revealed a solid start to the 2026 fiscal year, navigating a heavy investment phase as it scales production to meet global defense requirements.
